M
Marc A. Pfeffer
Researcher at Brigham and Women's Hospital
Publications - 815
Citations - 143710
Marc A. Pfeffer is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Heart failure & Myocardial infarction. The author has an hindex of 166, co-authored 765 publications receiving 133043 citations. Previous affiliations of Marc A. Pfeffer include Partners HealthCare & University of Miami.
Papers
More filters
Journal ArticleDOI
Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial
John J.V. McMurray,Inder S. Anand,Rafael Diaz,Aldo P. Maggioni,Christopher M. O'Connor,Marc A. Pfeffer,Krishna R. Polu,Scott D. Solomon,Yan Sun,Karl Swedberg,Michal Tendera,Dirk J. van Veldhuisen,Scott M. Wasserman,James B. Young +13 more
TL;DR: Patients with heart failure and anaemia have greater functional impairment, worse symptoms, increased rates of hospital admission, and a higher risk of death, compared with non‐anaemic HF patients.
Journal ArticleDOI
Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction.
Lars Køber,Karl Swedberg,John J.V. McMurray,Marc A. Pfeffer,Eric J. Velazquez,Rafael Diaz,Aldo P. Maggioni,Viatcheslav Mareev,Grzegorz Opolski,Frans Van de Werf,Faiez Zannad,Georg Ertl,Scott D. Solomon,Steven L. Zelenkofske,Jean-Lucien Rouleau,Jeffrey D. Leimberger,Robert M. Califf +16 more
TL;DR: To characterize the relationship between known and newly diagnosed atrial fibrillation and the risk of death and major cardiovascular events in patients with acute myocardial infarction complicated by heart failure and/or left ventricular systolic dysfunction, AF is characterized.
Journal ArticleDOI
Cholesterol and recurrent events: A secondary prevention trial for normolipidemic patients
Marc A. Pfeffer,Frank M. Sacks,Lemuel A. Moyé,Lisa E. Brown,Jean L. Rouleau,L. Howard Hartley,Jacques R. Rouleau,Richard H. Grimm,Francois Sestier,William J Wickemeyer,Thomas G. Cole,Eugene Braunwald +11 more
TL;DR: In this article, the authors used the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor pravastatin to reduce the sum of fatal coronary artery disease (CAD) and nonfatal myocardial infarction (Ml) in patients who have survived an Ml yet have a total cholesterol value.
Journal ArticleDOI
Adherence to medication according to sex and age in the CHARM programme.
Bradi B. Granger,Inger Ekman,Christopher B. Granger,Jan Östergren,Bertil Olofsson,Eric L. Michelson,John J.V. McMurray,Salim Yusuf,Marc A. Pfeffer,Karl Swedberg +9 more
TL;DR: This analysis investigates factors associated with adherence, with particular emphasis on age and sex, in patients with heart failure with incomplete adherence to prescribed medications.
Journal ArticleDOI
Influence of Previous Heart Failure Hospitalization on Cardiovascular Events in Patients With Reduced and Preserved Ejection Fraction
Natalie A. Bello,Brian Claggett,Akshay S. Desai,John J.V. McMurray,Christopher B. Granger,Salim Yusuf,Karl Swedberg,Marc A. Pfeffer,Scott D. Solomon +8 more
TL;DR: Rates of cardiovascular death or HF hospitalization are greatest in those who have been previously hospitalized for HF, and recent HFospitalization identifies a high-risk population for future clinical trials in HF and reduced ejection fraction and HF with preserved ejections fraction.